Search Results
Time for change: introducing genomic predictors in ER+ breast cancer
Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
Genome Science and Personalized Cancer Treatment
Genome-wide Association Studies and Breast Cancer Risk Prediction
What Changes Monday Morning? | Practice Applications in Breast Cancer | ER+ Disease
Genomic Biomarker for Predicting Response in Early Breast Cancer Patients
Molecular Testing in Breast Cancer: Will it Become Standard Practice? - Kimberly Allison, MD
Advancements in Care for Early-stage Breast Cancer 2024
Breast Cancer: Genomic Testing for Adjuvant Therapy
What's New in Screening and Treatment for Lobular Breast Cancer
Introduction: Subtyping Changes Treatment Approaches